ASHI 2015, y’all!

15/10/2015

The ASHI event went smashingly for Omixon yet again, with a full soccer-sized team of 11 making the trip from all corners of the US and across the pond from Europe – first to Atlanta, and then by minibus on a road trip to Savannah, Georgia. In among sweltering humidity...

Towards a New Gold Standard – NGS Corrections to Sanger SBT Genotyping Results

13/10/2015

Authors: Efi Melista, Krisztina Rigo, Agnes Pasztor, Mette Christiansen, Francesca Eleonora Bertinetto, Peter Meintjes, Tim Hague Aim: HLA typing is a crucial step prior to transplantation, particularly for bone marrow transplants. Correct allele matching is essential in order to increase the success of transplantation outcomes and decrease the rate of...

Omixon Holotype Early Access Program Featured at ASHI Annual Meeting 2015

23/09/2015

Omixon announce today that Holotype HLA™ and other Omixon products will be featured in four oral presentations and 12 poster presentations at the annual meeting of the American Society for Histocompatibility and Immunogenetics (ASHI) in Savannah, Georgia. Additionally, in the Tuesday Vendor Symposium, Omixon’s CEO, Tim Hague, will present extended results...

NGS Workshops on Holotype HLA™ and HLA Twin™ at ASHI 2015

14/08/2015

Join us for a “power hour” Basic and Advanced workshop series at this year’s ASHI Meeting in Savannah. The Omixon Academy Training Series is ABHI approved and Certificate of Attendance will be available for attendees that stay for the duration of the event (1hr is 0.15CECs). BASIC Event Introduction...

Join Us for the Holotype EAP Success Symposium at ASHI 2015

13/08/2015

The Holotype Early Access Program was formally announced at ASHI 2014 in Denver, and ran until 2015 July. 24 labs across 13 countries have been trained in the use of Holotype HLA and have genotyped hundreds of their own samples. Three early adopters will present their own experience with Holotype...